Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 36, 2024 - Issue 8
38
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Willingness to use PrEP among PrEP naïve men who have sex with men: a meta-analysis

ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1148-1161 | Received 06 Oct 2023, Accepted 07 May 2024, Published online: 21 May 2024

References

  • Algarin, A. B., Shrader, C. H., Bhatt, C., Hackworth, B. T., Cook, R. L., & Ibañez, G. E. (2019). The pre-exposure prophylaxis (PrEP) continuum of care and correlates to initiation among HIV-negative men recruited at Miami Gay Pride 2018. Journal of Urban Health, 96(6), 835–844. https://doi.org/10.1007/s11524-019-00362-4
  • Ali, S. S., Mumtaz, A., Qamar, M. A., Tebha, S. S., Parhin, A., Butt, M., & Essar, M. Y. (2022). New-onset Parkinsonism as a Covid-19 infection sequela: A systematic review and meta-analysis. Annals of Medicine and Surgery, 80, 104281. https://doi.org/10.1016/j.amsu.2022.104281
  • Al-Tayyib, A. A., Thrun, M. W., Haukoos, J. S., & Walls, N. E. (2014). Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in Denver, Colorado. AIDS Behavior, 18 Suppl 3(S3), 340–347. https://doi.org/10.1007/s10461-013-0553-6
  • Aromataris, E., & Munn, Z. (2020). JBI manual for evidence synthesis. JBI. https://synthesismanual.jbi.global
  • Beymer, M. R., Gildner, J. L., Holloway, I. W., & Landovitz, R. J. (2018). Acceptability of injectable and on-demand pre-exposure prophylaxis among an online sample of young men who have sex with men in California. LGBT Health, 5(6), 341–349. https://doi.org/10.1089/lgbt.2017.0244
  • Bland, S. (2023, February 2). USPSTF recommendation for PrEP: Reflections on insurance coverage and HIV prevention for older adults | O’Neill Institute. https://oneill.law.georgetown.edu/uspstf-recommendation-for-prep-reflections-on-insurance-coverage-and-hiv-prevention-for-older-adults/
  • Borenstein, M. (2020). Research note: In a meta-analysis, the I2 index does not tell us how much the effect size varies across studies. Journal of Physiotherapy, 66(2), 135–139. https://doi.org/10.1016/j.jphys.2020.02.011
  • Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2022). Comprehensive meta-analysis version 3. Biostat, Englewood, NJ.
  • Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2010). A basic introduction to fixed-effect and random-effects models for meta-analysis. Research Synthesis Methods, 1(2), 97–111. https://doi.org/10.1002/jrsm.12
  • Centers for Disease Control and Prevention. (2018a). Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: Clinical providers’ supplement. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-provider-supplement-2017.pdf
  • Centers for Disease Control and Prevention. (2018b). Centers for Disease Control and Prevention. HIV Surveillance Report, 2018 (Updated) (31; p. 119). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
  • Centers for Disease Control and Prevention. (2021). Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021;26(No.2). https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-26-no-2/index.html
  • Centers for Disease Control and Prevention. (2023). Volume 34 | HIV Surveillance | Reports | Resource Library | HIV/AIDS | CDC. https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-34/index.html
  • Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., Chuachoowong, R., Gvetadze, R. J., McNicholl, J. M., Paxton, L. A., Curlin, M. E., Hendrix, C. W., & Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. https://doi.org/10.1016/S0140-6736(13)61127-7
  • Deeks, J. J., Higgins, J. P., Altman, D. G., & Group on behalf of the Cochrane Statistical Methods. (2019). Analysing data and undertaking meta-analyses. In Cochrane handbook for systematic reviews of interventions: Vol. Version 6.3 (pp. 241–284). Cochrane, Wiley. www.training.cochrane.org/handbook
  • DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7(3), 177–188. https://doi.org/10.1016/0197-2456(86)90046-2
  • Dunville, R., Harper, C., Johns, M. M., Heim Viox, M., Avripas, S., Fordyce, E., Stern, M., Schlissel, A., Carpenter, R., & Michaels, S. (2021). Awareness and willingness to use biomedical prevention strategies for HIV among sexual and gender minority youth: Results from a national survey. Journal of Adolescent Health, 68(1), 199–206. Embase. https://doi.org/10.1016/j.jadohealth.2020.05.032
  • Duval, S., & Tweedie, R. (2000). Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56(2), 455–463. https://doi.org/10.1111/j.0006-341X.2000.00455.x
  • Fallon, S. A., Park, J. N., Ogbue, C. P., Flynn, C., & German, D. (2017). Awareness and acceptability of pre-exposure HIV prophylaxis among men who have sex with men in Baltimore. AIDS and Behavior, 21(5), 1268–1277. Medline. https://doi.org/10.1007/s10461-016-1619-z
  • Finlayson, T. (2019). Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. MMWR. Morbidity and Mortality Weekly Report, 68(27), 597–603. https://doi.org/10.15585/mmwr.mm6827a1
  • Foster, V., Clark, P. C., Holstad, M. M., & Burgess, E. (2012). Factors associated with risky sexual behaviors in older adults. The Journal of the Association of Nurses in AIDS Care: JANAC, 23(6), 487–499. https://doi.org/10.1016/j.jana.2011.12.008
  • Goswami, S., Barnard, M., Bentley, J. P., Bhattacharya, K., Kang, M., & Gannon, T. (2023). Factors associated with the willingness to use different modes of HIV pre – exposure prophylaxis (PrEP)—A meta-analysis. PROSPERO 2020 CRD42020220968. https://www.crd.york.ac.uk/prospero/display_record.php?ID = CRD42020220968
  • Grov, C., Rendina, H. J., Jimenez, R., & Parsons, J. T. (2016a). Using online settings to identify gay and bisexual men willing to take or with experience taking PrEP: Implications for researchers and providers. AIDS Education and Prevention, 28(5), 378–392. https://doi.org/10.1521/aeap.2016.28.5.378
  • Grov, C., Rendina, H. J., Whitfield, T. H., Ventuneac, A., & Parsons, J. T. (2016b). Changes in familiarity with and willingness to take preexposure prophylaxis in a longitudinal study of highly sexually active gay and bisexual men. LGBT Health, 3(4), 252–257. Medline. https://doi.org/10.1089/lgbt.2015.0123
  • Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560. https://doi.org/10.1136/bmj.327.7414.557
  • HIV.gov. (2021). What is ending the HIV epidemic in the U.S.? HIV.Gov. https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview
  • HIV.gov. (2023). HIV & AIDS trends and U.S. statistics overview. HIV.Gov. https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics
  • Holloway, I. W., Tan, D., Gildner, J. L., Beougher, S. C., Pulsipher, C., Montoya, J. A., Plant, A., & Leibowitz, A. (2017). Facilitators and barriers to pre-exposure prophylaxis willingness among young men who have sex with men who use geosocial networking applications in California. AIDS Patient Care and STDs, 31(12), 517–527. Embase. https://doi.org/10.1089/apc.2017.0082
  • Jenness, S. M., Maloney, K. M., Smith, D. K., Hoover, K. W., Goodreau, S. M., Rosenberg, E. S., Weiss, K. M., Liu, A. Y., Rao, D. W., & Sullivan, P. S. (2019). Addressing gaps in HIV preexposure prophylaxis care to reduce racial disparities in HIV incidence in the United States. American Journal of Epidemiology, 188(4), 743–752. https://doi.org/10.1093/aje/kwy230
  • Kamitani, E., Wichser, M. E., Mizuno, Y., DeLuca, J. B., & Higa, D. H. (2023). What factors are associated with willingness to use HIV pre-exposure prophylaxis (PrEP) among U.S. men who have sex with men not on PrEP? A systematic review and meta-analysis. Journal of the Association of Nurses in AIDS Care, 34(2), 135. https://doi.org/10.1097/JNC.0000000000000384
  • Kanny, D. (2019). Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men—23 urban areas, 2017. MMWR. Morbidity and Mortality Weekly Report, 68(37), https://doi.org/10.15585/mmwr.mm6837a2
  • Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., del Rio, C., Sullivan, P. S., & Rosenberg, E. S. (2015). Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 61(10), 1590–1597. https://doi.org/10.1093/cid/civ664
  • Klein, H., & Washington, T. A. (2020). Older versus younger men who have sex with men: Awareness of and potential barriers to the use of pre-exposure prophylaxis (PrEP) medication to prevent the transmission of HIV. Journal of AIDS and HIV Treatment, 2(2), Article Issue 2. https://doi.org/10.33696/AIDS.2.006
  • Li, J., Berg, C. J., Kramer, M. R., Haardörfer, R., Zlotorzynska, M., & Sanchez, T. H. (2019). An integrated examination of county- and individual-level factors in relation to HIV pre-exposure prophylaxis awareness, willingness to use, and uptake among men who have sex with men in the US. AIDS Behavior, 23(7), 1721–1736. https://doi.org/10.1007/s10461-018-2334-8
  • Meyers, K., Rodriguez, K., Moeller, R. W., Gratch, I., Markowitz, M., & Halkitis, P. N. (2014). High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: A P18 cohort substudy. PLoS One, 9(12), e114700. https://doi.org/10.1371/journal.pone.0114700
  • Ojikutu, B. O., Bogart, L. M., Higgins-Biddle, M., Dale, S. K., Allen, W., Dominique, T., & Mayer, K. H. (2018). Facilitators and barriers to pre-exposure prophylaxis (PrEP) use among black individuals in the United States: Results from the national survey on HIV in the black community (NSHBC). AIDS and Behavior, 22(11), 3576–3587. https://doi.org/10.1007/s10461-018-2067-8
  • Orel, N. A., Spence, M., & Steele, J. (2005). Getting the message out to older adults: Effective HIV health education risk reduction publications. Journal of Applied Gerontology, 24(5), 490–508. https://doi.org/10.1177/0733464805279155
  • Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
  • Peng, P., Su, S., Fairley, C. K., Chu, M., Jiang, S., Zhuang, X., & Zhang, L. (2018). A global estimate of the acceptability of pre-exposure prophylaxis for HIV among men who have sex with men: A systematic review and meta-analysis. AIDS and Behavior, 22(4), 1063–1074. https://doi.org/10.1007/s10461-017-1675-z
  • Pomery, E. A., Gibbons, F. X., Reis-Bergan, M., & Gerrard, M. (2009). From willingness to intention: Experience moderates the shift from reactive to reasoned behavior. Personality & Social Psychology Bulletin, 35(7), 894–908. https://doi.org/10.1177/0146167209335166
  • Reif, S. S., Whetten, K., Wilson, E. R., McAllaster, C., Pence, B. W., Legrand, S., & Gong, W. (2014). HIV/AIDS in the southern USA: A disproportionate epidemic. AIDS Care, 26(3), 351–359. https://doi.org/10.1080/09540121.2013.824535
  • Rendina, H. J., Whitfield, T. H. F., Grov, C., Starks, T. J., & Parsons, J. T. (2017). Distinguishing hypothetical willingness from behavioral intentions to initiate HIV pre-exposure prophylaxis (PrEP): Findings from a large cohort of gay and bisexual men in the U.S. Social Science & Medicine, 172, 115–123. https://doi.org/10.1016/j.socscimed.2016.10.030
  • Rolle, C.-P., Rosenberg, E. S., Luisi, N., Grey, J., Sanchez, T., del Rio, C., Peterson, J. L., Frew, P. M., Sullivan, P. S., & Kelley, C. F. (2017). Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia. International Journal of STD and AIDS, 28(9), 849–857. Embase. https://doi.org/10.1177/0956462416675095
  • Rossiter, S., Sharpe, J. D., Pampati, S., Sanchez, T., Zlotorzynska, M., & Jones, J. (2021). Differences in PrEP awareness, discussions with healthcare providers, and use among men who have sex with men in the United States by urbanicity and region: A cross-sectional analysis. AIDS and Behavior, 25(12), 4102–4114. Medline. https://doi.org/10.1007/s10461-021-03267-z
  • Russ, S., Zhang, C., & Liu, Y. (2021). Pre-exposure prophylaxis care continuum, barriers, and facilitators among black men who have sex with men in the United States: A systematic review and meta-analysis. AIDS and Behavior, 25(7), 2278–2288. https://doi.org/10.1007/s10461-020-03156-x
  • Sekhon, M., Cartwright, M., & Francis, J. J. (2017). Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework. BMC Health Services Research, 17(1), 88. https://doi.org/10.1186/s12913-017-2031-8
  • Sullivan, P. S., Sanchez, T. H., Zlotorzynska, M., Chandler, C. J., Sineath, R. C., Kahle, E., & Tregear, S. (2020). National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017. Journal of the International AIDS Society, 23(3), e25461. https://doi.org/10.1002/jia2.25461
  • U.S. Food and Drug Administration. (2021). FDA approves first injectable treatment for HIV pre-exposure prevention. FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
  • Ward, L. M., Bruce, M. A., Thorpe, R. J. J., Mena, L., Nunn, A., & Crosby, R. (2019). Correlates associated with willingness to start pre-exposure prophylaxis among young black men who have sex with men (MSM) in Jackson, Mississippi. Family & Community Health, 42(3), 189–196. https://doi.org/10.1097/FCH.0000000000000225
  • Yi, S., Tuot, S., Mwai, G. W., Ngin, C., Chhim, K., Pal, K., Igbinedion, E., Holland, P., Choub, S. C., & Mburu, G. (2017). Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: A systematic review and meta-analysis. Journal of the International AIDS Society, 20(1), 21580. https://doi.org/10.7448/IAS.20.1.21580

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.